What is the best management for a 55-year-old man with hypertension, obesity, a history of nephrolithiasis, recent frothy urine suggesting proteinuria, and acute back pain relieved by acetaminophen?

Management of Suspected Glomerular Disease with Proteinuria

This patient requires urgent diagnostic workup for glomerular disease with immediate urine studies (urinalysis with microscopy, spot urine protein-to-creatinine ratio), comprehensive metabolic panel, and consideration of renal imaging to differentiate between active kidney stone disease versus new-onset proteinuric kidney disease.

Immediate Diagnostic Priorities

The frothy urine strongly suggests significant proteinuria, which fundamentally changes the clinical picture from simple recurrent nephrolithiasis. The back pain that resolved with acetaminophen could represent either:

• Kidney stone passage (given his history)
• Renal parenchymal pain from glomerular disease
• Unrelated musculoskeletal pain

Critical first steps:

• Quantify proteinuria with spot urine protein-to-creatinine ratio or albumin-to-creatinine ratio 1
• Assess kidney function with serum creatinine and eGFR 2
• Examine urine sediment for red cell casts, acanthocytes, or dysmorphic RBCs to distinguish glomerular from non-glomerular hematuria 1
• Non-contrast CT or renal ultrasound to evaluate for obstructing stones versus other structural abnormalities

Blood Pressure Management Strategy

Given his hypertension and suspected proteinuria, blood pressure control becomes paramount for preventing progression of kidney disease.

Target blood pressure: <120/80 mmHg 1, 2

Antihypertensive Medication Selection

Critical caveat regarding ACE inhibitors/ARBs: The KDIGO 2021 guidelines explicitly warn DO NOT start ACEi/ARB in patients with abrupt onset nephrotic syndrome, as these drugs can cause acute kidney injury, especially in minimal change disease 1. This is a crucial pitfall to avoid.

Initial approach:

• If proteinuria is confirmed but not nephrotic-range (i.e., <3.5 g/day) and kidney function is stable: Start ACEi or ARB as first-line therapy, uptitrating to maximally tolerated dose 1
• If nephrotic syndrome is suspected (frothy urine suggests heavy proteinuria): Delay ACEi/ARB initiation until the underlying cause is determined and you can rule out minimal change disease or FSGS that might respond rapidly to immunosuppression 1
• Use alternative antihypertensives (calcium channel blockers, beta-blockers) initially if nephrotic syndrome is suspected
• Add loop diuretics if edema develops 1

Monitoring on ACEi/ARB

If ACEi/ARB is initiated:

• Monitor labs frequently (creatinine, potassium) 1
• Accept up to 30% increase in serum creatinine if stable 1
• Stop if: kidney function continues worsening OR refractory hyperkalemia develops 1
• Counsel patient to hold ACEi/ARB during volume depletion or sick days 1

Lifestyle Modifications (Essential Component)

These interventions address his obesity, hypertension, and kidney stone risk simultaneously 1:

• Sodium restriction to <2.0 g/day (<90 mmol/day) - critical for both proteinuria reduction and blood pressure control
• Weight normalization - obesity drives hypertension through renal sodium retention, RAAS activation, and sympathetic nervous system activation 3, 4, 5
• Regular exercise
• Smoking cessation if applicable

The obesity-hypertension-kidney disease triad is particularly concerning, as visceral adiposity causes physical kidney compression, glomerular hyperfiltration, and progressive injury 3, 4, 6.

Kidney Stone Considerations

His history of nephrolithiasis with hypertension and obesity fits the metabolic syndrome pattern 7, 8. The association between recurrent stones and progressive kidney function loss is well-established, particularly in older patients with multiple symptomatic episodes 9.

If active stone disease is confirmed:

• Continue acetaminophen for pain management as needed (safe when used appropriately) 10
• Avoid NSAIDs given potential proteinuria/kidney disease
• Metabolic stone evaluation after acute episode resolves
• The same dietary sodium restriction benefits both proteinuria and stone prevention 8

Proteinuria-Specific Management

Once proteinuria is quantified:

Goal: Reduce proteinuria to <1 g/day (variable by disease) 1

Sequential approach:

1. Maximize blood pressure control with target <120/80 mmHg
2. Implement strict sodium restriction
3. If proteinuria persists despite maximal medical therapy, consider mineralocorticoid receptor antagonists (monitor potassium closely) 1
4. Consider statin therapy given hypertension as cardiovascular risk factor 1

What NOT to Do

• Do not empirically start ACEi/ARB before confirming the degree of proteinuria and ruling out abrupt-onset nephrotic syndrome 1
• Do not ignore the frothy urine - this requires immediate investigation
• Do not assume back pain is simply another stone without imaging confirmation
• Do not use NSAIDs for pain management in the setting of suspected kidney disease

Next Steps Algorithm

1. Today: Order urinalysis with microscopy, spot urine protein-to-creatinine ratio, comprehensive metabolic panel, CBC
2. If proteinuria confirmed: Refer to nephrology for consideration of kidney biopsy if proteinuria is nephrotic-range or unexplained
3. If imaging shows active stone: Manage stone acutely, but still pursue proteinuria workup
4. Blood pressure management: Start with non-RAAS blocker if nephrotic syndrome suspected; otherwise ACEi/ARB after confirming proteinuria level and stable kidney function
5. Immediate lifestyle counseling: Sodium restriction and weight loss program

The combination of obesity, hypertension, kidney stones, and new proteinuria suggests either obesity-related glomerulopathy 6 or another primary glomerular disease - both require prompt diagnosis and aggressive risk factor modification to prevent progression to chronic kidney disease.